Dr. Maria Berghs, Visiting Associate Professor, University of Cambridge, United Kingdom
Dr. Bola Ola, Professor, Lagos State University, Nigeria/ Consultant psychiatrist based in Drayton in Queensland, Australia
Dr. Anna Cronin de Chavez, Research Fellow, London School of Hygiene and Tropical Medicine, United Kingdom
Dr. Bassey Ebenso, University of Leeds, United Kingdom
Publications
Ola, B., Olushola, O., Ebenso, B. & Berghs, M. (2024). Sickle Cell Disorder and Its Psychosocial Burdens in Africa. In Sickle Cell Disease in Sub-Saharan Africa Public Health Perspectives. Bukola, B., Kanayo,K & Inusa, B. (eds.) Sickle Cell Disease in Sub-Saharan Africa | Public Health Perspectives (taylorfrancis.com)
Berghs, M., Ebenso, B. & Ola B. (2024). The Social Determinants of Severity in Sickle Cell. In Sickle Cell Disease in Sub-Saharan Africa Public Health Perspectives. Bukola, B., Kanayo,K & Inusa, B. (eds.) Sickle Cell Disease in Sub-Saharan Africa | Public Health Perspectives (taylorfrancis.com)
Berghs, M. (2024). The Critical Importance of Global Collaboration in Sickle Cell Advocacy and Management. In Sickle Cell Disorders in Sub-Saharan Africa. Bukola, B., Kanayo,K & Inusa, B. (eds.) Sickle Cell Disease in Sub-Saharan Africa | Public Health Perspectives (taylorfrancis.com)
Berghs, M. (2024). Bridging the Gap. In Sickle Cell Disorders in Sub-Saharan Africa. Bukola, B., Kanayo,K & Inusa, B. (eds.) Sickle Cell Disease in Sub-Saharan Africa | Public Health Perspectives (taylorfrancis.com)
Berghs, M. & Ebenso, B. (2023). Social Science Research & Sickle Cell. In Handbook of Social Sciences and Global Public Health. Liamputtong, P. (Eds), Cham: Springer. https://link.springer.com/referencework/10.1007/978-3-030-96778-9?page=1#toc
Berghs, M. (2022). Let’s Get Back to Normal? COVID-19 and the Logic of Cure. Frontiers in Sociology, 7, 782582. Frontiers | Let’s Get Back to Normal? COVID-19 and the Logic of Cure
Berghs, M., Ola, B., De Chavez, A. C., & Ebenso, B. (2020). Time to apply a social determinants of health lens to addressing sickle cell disorders in sub-Saharan Africa. BMJ global health, 5(7), e002601. https://gh.bmj.com/content/5/7/e002601.abstract
Evidence
We give national and international evidence and are advisory members of committees. This is some of the national evidence we have given:
We have given verbal and written evidence to UK parliament on impact of personalised medicine for blood disorders:
Sickle cell and beta thalassemia: what are the treatment options and challenges? – POST
During the COVID-19 pandemic we gave written evidence to the UK parliament on impact of health inequalities:
committees.parliament.uk/writtenevidence/2967/pdf/
COVID-19 parliamentary expertise on health inequalities: